Trends in pancreatic cancer incidence and mortality in the United States from 2000 to 2019; a SEER based study
Oluseyi Abidoye(Mayo Clinic), Hasan Choudhury(Northeast Georgia Medical Center), Young Min Cho(Northeast Georgia Medical Center), Comfort Adewunmi(Piedmont Cancer Institute), Sheena Bhushan(Northeast Georgia Medical Center)
Cited by 2
Related Papers
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population
|European Journal of Cancer|2024|47
Circulating Tumor DNA Testing for Minimal Residual Disease and Its Application in Colorectal Cancer
|Cells|2025|19
Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population
|The Oncologist|2024|10